chr17-18137652-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_016239.4(MYO15A):c.4848C>G(p.Phe1616Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000642 AC: 16AN: 249384Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135332
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461840Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727216
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74382
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:2
- -
- -
not specified Uncertain:1
The p.Phe1616Leu variant in MYO15A has not been reported in individuals with hea ring loss, but has been identified in 4/65798 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs368430972) . Computational analyses (biochemical amino acid properties, conservation, Align GVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impac t to the protein. In summary, the clinical significance of this variant cannot b e determined without additional data. -
MYO15A-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at